Vitronectin Antikörper (N-Term)
Kurzübersicht für Vitronectin Antikörper (N-Term) (ABIN929041)
Target
Alle Vitronectin (VTN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- VTN antibody was raised in rabbit using the N terminal of VTN as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
VTN Blocking Peptide, catalog no. 33R-2310, is also available for use as a blocking control in assays to test for specificity of this VTN antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Vitronectin (VTN)
-
Andere Bezeichnung
- VTN
-
Hintergrund
- VTN is a member of the pexin family. It is found in serum and tissues and promotes cell adhesion and spreading, inhibits the membrane-damaging effect of the terminal cytolytic complement pathway, and binds to several serpin serine protease inhibitors. It is a secreted protein and exists in either a single chain form or a clipped, two chain form held together by a disulfide bond. Synonyms: Polyclonal VTN antibody, Anti-VTN antibody, vitronectin antibody, V75 antibody, VN antibody, VNT antibody.
-
Pathways
- Autophagie, Smooth Muscle Cell Migration
Target
-